Physician profile
Rawad Mounzer
NPI 1154554236
$22,126.11
in general payments reported to CMS, 2019-2025
25 companies · $1,799 in 2025
The $1,799 reported for 2025 was more than what 76% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,151 · 2020: $1,245 · 2021: $6,680 · 2022: $4,015 · 2023: $5,031 · 2024: $2,205 · 2025: $1,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Food and Beverage: $3,021 · Travel and Lodging: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Food and Beverage | $3,020.51 |
| Travel and Lodging | $514.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $13,837.02 | 2019-2024 | Conmed Gastrostomy, Biliary Cannulas, Conmed Biliary |
| W. L. Gore & Associates, INC. | $3,105.00 | 2022 | |
| Merit Medical Systems INC | $819.80 | 2020-2025 | Esophyx, Esophageal Stent/Delivery System, Endomaxx Stent and Delivery System |
| Abbvie INC. | $758.24 | 2019-2025 | |
| Boston Scientific Corporation | $737.30 | 2019-2025 | Axios, Wallflex Duodenal, Spyglass |
| Fujifilm Healthcare Americas Corporation | $519.68 | 2020-2025 | |
| Olympus America INC. | $512.26 | 2019-2025 | Evis Exera III Colonovideoscope, Gastrointestinal Videoscope, Hanarostent Esophagus Tts(Ccc) |
| Apollo Endosurgery US INC | $290.79 | 2022 | |
| Creo Medical INC. | $243.04 | 2023 | Speedboat |
| Endogastric Solutions, INC | $204.12 | 2024 | Esophyx |
| Medtronic, INC. | $190.77 | 2023-2025 | Nexpowder, Endoflip, Prodigi |
| Ambu INC. | $139.13 | 2020-2021 | |
| Erbe USA INC | $120.56 | 2022 | |
| Intuitive Surgical, INC. | $116.76 | 2025 | |
| Lumendi LLC | $94.68 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pentax of America, INC. | $84.02 | 2025 | Pentax Medical, C2 Cryoballoon Focal Controller, Inspira |
| Omega Medical Imaging, LLC | $82.84 | 2025 | |
| Shionogi INC | $75.63 | 2019-2020 | |
| Amgen INC. | $54.57 | 2025 | Uplizna |
| Genzyme Corporation | $34.13 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $32.53 | 2024 | Dupixent |
| Pinnacle Biologics, INC | $22.96 | 2025 | Photofrin |
| Aimmune Therapeutics, INC. | $21.70 | 2025 | Zenpep |
| Csl Behring | $14.50 | 2020 | |
| Viiv Healthcare Company | $14.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rawad Mounzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.